ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Gross of the placeholder expense ratio and trading costs · not investor results
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1LLY | ELI LILLY & CO | Healthcare | $1.34T | 17.35% |
2JNJ | JOHNSON & JOHNSON | Healthcare | $682.52B | 8.82% |
3ABBV | ABBVIE INC | Healthcare | $520.47B | 6.73% |
4PG | PROCTER & GAMBLE CO | Consumer Defensive | $389.46B | 5.03% |
5MRK | MERCK & CO INC | Healthcare | $362.27B | 4.68% |
6NFLX | NETFLIX INC | Communication Services | $257.43B | 3.33% |
7AMGN | AMGEN INC | Healthcare | $252.64B | 3.26% |
8DIS | WALT DISNEY CO | Communication Services | $204.15B | 2.64% |
9MCD | MCDONALDS CORP | Consumer Cyclical | $193.12B | 2.50% |
10ABT | ABBOTT LABORATORIES | Healthcare | $185.75B | 2.40% |
11PFE | PFIZER INC | Healthcare | $164.33B | 2.12% |
12ISRG | INTUITIVE SURGICAL INC | Healthcare | $152.49B | 1.97% |
13VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | $137.57B | 1.78% |
14MDT | MEDTRONIC PLC | Healthcare | $129.18B | 1.67% |
15BMY | BRISTOL MYERS SQUIBB CO | Healthcare | $127.39B | 1.65% |
16SBUX | STARBUCKS CORP | Consumer Cyclical | $122.28B | 1.58% |
17SYK | STRYKER CORP | Healthcare | $118.92B | 1.54% |
18MAR | MARRIOTT INTERNATIONAL INC | Consumer Cyclical | $109.35B | 1.41% |
19REGN | REGENERON PHARMACEUTICALS INC | Healthcare | $98.40B | 1.27% |
20MMM | 3M CO | Industrials | $96.24B | 1.24% |
21ECL | ECOLAB INC | Basic Materials | $85.38B | 1.10% |
22HLT | HILTON WORLDWIDE HOLDINGS INC | Consumer Cyclical | $82.93B | 1.07% |
23CL | COLGATE PALMOLIVE CO | Consumer Defensive | $77.82B | 1.01% |
24BSX | BOSTON SCIENTIFIC CORP | Healthcare | $64.07B | 0.83% |
25EW | EDWARDS LIFESCIENCES CORP | Healthcare | $60.84B | 0.79% |
26BDX | BECTON DICKINSON & CO | Healthcare | $58.76B | 0.76% |
27IDXX | IDEXX LABORATORIES INC | Healthcare | $54.99B | 0.71% |
28MDLN | MEDLINE INC | Healthcare | $52.59B | 0.68% |
29TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Healthcare | $50.93B | 0.66% |
30ONC | BEONE MEDICINES LTD | Healthcare | $47.50B | 0.61% |
31CMG | CHIPOTLE MEXICAN GRILL INC | Consumer Cyclical | $44.49B | 0.57% |
32YUM | YUM BRANDS INC | Consumer Cyclical | $42.74B | 0.55% |
33LYV | LIVE NATION ENTERTAINMENT INC | Communication Services | $42.46B | 0.55% |
34EL | ESTEE LAUDER COMPANIES INC | Consumer Defensive | $40.04B | 0.52% |
35RPRX | ROYALTY PHARMA PLC | Healthcare | $39.56B | 0.51% |
36BIIB | BIOGEN INC | Healthcare | $37.03B | 0.48% |
37GEHC | GE HEALTHCARE TECHNOLOGIES INC | Healthcare | $37.00B | 0.48% |
38TKO | TKO GROUP HOLDINGS INC | Communication Services | $36.60B | 0.47% |
39ZTS | ZOETIS INC | Healthcare | $33.71B | 0.44% |
40RMD | RESMED INC | Healthcare | $33.60B | 0.43% |
41SN | SHARKNINJA INC | Consumer Cyclical | $31.02B | 0.40% |
42DXCM | DEXCOM INC | Healthcare | $30.35B | 0.39% |
43ECHO | ECHOSTAR CORP | Communication Services | $28.55B | 0.37% |
44CHD | CHURCH & DWIGHT CO INC | Consumer Defensive | $26.37B | 0.34% |
45QSR | RESTAURANT BRANDS INTERNATIONAL INC | Consumer Cyclical | $26.29B | 0.34% |
46DRI | DARDEN RESTAURANTS INC | Consumer Cyclical | $25.79B | 0.33% |
47UTHR | UNITED THERAPEUTICS CORP | Healthcare | $25.27B | 0.33% |
48LVS | LAS VEGAS SANDS CORP | Consumer Cyclical | $24.66B | 0.32% |
49STE | STERIS PLC | Healthcare | $24.61B | 0.32% |
50VTRS | VIATRIS INC | Healthcare | $23.70B | 0.31% |
51ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | $20.98B | 0.27% |
52ZBH | ZIMMER BIOMET HOLDINGS INC | Healthcare | $19.79B | 0.26% |
53FSLR | FIRST SOLAR INC | Technology | $18.52B | 0.24% |
54H | HYATT HOTELS CORP | Consumer Cyclical | $17.48B | 0.23% |
55NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | $17.15B | 0.22% |
56YUMC | YUM CHINA HOLDINGS INC | Consumer Cyclical | $16.58B | 0.21% |
57WMG | WARNER MUSIC GROUP CORP | Communication Services | $16.57B | 0.21% |
58CRCL | CIRCLE INTERNET GROUP INC | Financial Services | $16.37B | 0.21% |
59JAZZ | JAZZ PHARMACEUTICALS PLC | Healthcare | $15.43B | 0.20% |
60SOLV | SOLVENTUM CORP | Healthcare | $15.07B | 0.19% |
61ARMK | ARAMARK | Industrials | $14.20B | 0.18% |
62SGI | SOMNIGROUP INTERNATIONAL INC | Consumer Cyclical | $13.96B | 0.18% |
63BAX | BAXTER INTERNATIONAL INC | Healthcare | $13.32B | 0.17% |
64ELAN | ELANCO ANIMAL HEALTH INC | Healthcare | $13.25B | 0.17% |
65CLX | CLOROX CO | Consumer Defensive | $13.11B | 0.17% |
66PEN | PENUMBRA INC | Healthcare | $12.64B | 0.16% |
67TXRH | TEXAS ROADHOUSE INC | Consumer Cyclical | $12.21B | 0.16% |
68COO | COOPER COMPANIES INC | Healthcare | $11.83B | 0.15% |
69ALGN | ALIGN TECHNOLOGY INC | Healthcare | $11.77B | 0.15% |
70HALO | HALOZYME THERAPEUTICS INC | Healthcare | $11.48B | 0.15% |
71TECH | BIO-TECHNE CORP | Healthcare | $11.44B | 0.15% |
72BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $10.98B | 0.14% |
73RGEN | REPLIGEN CORP | Healthcare | $10.64B | 0.14% |
74PODD | INSULET CORP | Healthcare | $10.36B | 0.13% |
75LTH | LIFE TIME GROUP HOLDINGS INC | Consumer Cyclical | $10.23B | 0.13% |
76VSAT | VIASAT INC | Technology | $9.92B | 0.13% |
77TGTX | TG THERAPEUTICS INC | Healthcare | $9.76B | 0.13% |
78GMED | GLOBUS MEDICAL INC | Healthcare | $9.58B | 0.12% |
79AMKR | AMKOR TECHNOLOGY INC | Technology | $9.20B | 0.12% |
80KRYS | KRYSTAL BIOTECH INC | Healthcare | $9.06B | 0.12% |
81PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | $8.77B | 0.11% |
82AOS | SMITH A O CORP | Industrials | $8.59B | 0.11% |
83WYNN | WYNN RESORTS LTD | Consumer Cyclical | $8.51B | 0.11% |
84MGM | MGM RESORTS INTERNATIONAL | Consumer Cyclical | $8.41B | 0.11% |
85EAT | BRINKER INTERNATIONAL INC | Consumer Cyclical | $8.21B | 0.11% |
86CORT | CORCEPT THERAPEUTICS INC | Healthcare | $8.07B | 0.10% |
87ALKS | ALKERMES PLC | Healthcare | $7.89B | 0.10% |
88KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | Healthcare | $7.56B | 0.10% |
89AMRX | AMNEAL PHARMACEUTICALS INC | Healthcare | $7.56B | 0.10% |
90BLCO | BAUSCH & LOMB CORP | Healthcare | $7.56B | 0.10% |
91CHDN | CHURCHILL DOWNS INC | Consumer Cyclical | $6.83B | 0.09% |
92MSA | MSA SAFETY INC | Industrials | $6.73B | 0.09% |
93ELF | ELF BEAUTY INC | Consumer Defensive | $6.71B | 0.09% |
94CAVA | CAVA GROUP INC | Consumer Cyclical | $6.70B | 0.09% |
95LNTH | LANTHEUS HOLDINGS INC | Healthcare | $6.62B | 0.09% |
96LGND | LIGAND PHARMACEUTICALS INC | Healthcare | $6.33B | 0.08% |
97TFX | TELEFLEX INC | Healthcare | $6.07B | 0.08% |
98CRUS | CIRRUS LOGIC INC | Technology | $6.07B | 0.08% |
99CZR | CAESARS ENTERTAINMENT INC | Consumer Cyclical | $5.97B | 0.08% |
100BROS | DUTCH BROS INC | Consumer Cyclical | $5.89B | 0.08% |
101WH | WYNDHAM HOTELS & RESORTS INC | Consumer Cyclical | $5.75B | 0.07% |
102HAE | HAEMONETICS CORP | Healthcare | $5.59B | 0.07% |
103BYD | BOYD GAMING CORP | Consumer Cyclical | $5.45B | 0.07% |
104MTN | VAIL RESORTS INC | Consumer Cyclical | $5.39B | 0.07% |
105CAKE | CHEESECAKE FACTORY INC | Consumer Cyclical | $5.29B | 0.07% |
106PTCT | PTC THERAPEUTICS INC | Healthcare | $5.29B | 0.07% |
107CHH | CHOICE HOTELS INTERNATIONAL INC | Consumer Cyclical | $5.26B | 0.07% |
108MMSI | MERIT MEDICAL SYSTEMS INC | Healthcare | $5.19B | 0.07% |
109RRR | RED ROCK RESORTS INC | Consumer Cyclical | $5.19B | 0.07% |
110EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | $5.02B | 0.06% |
111LIVN | LIVANOVA PLC | Healthcare | $4.97B | 0.06% |
112CNK | CINEMARK HOLDINGS INC | Communication Services | $4.80B | 0.06% |
113TNL | TRAVEL & LEISURE CO | Consumer Cyclical | $4.71B | 0.06% |
114SPHR | SPHERE ENTERTAINMENT CO | Communication Services | $4.49B | 0.06% |
115PLNT | PLANET FITNESS INC | Consumer Cyclical | $4.48B | 0.06% |
116ICUI | ICU MEDICAL INC | Healthcare | $4.43B | 0.06% |
117WING | WINGSTOP INC | Consumer Cyclical | $4.31B | 0.06% |
118VSH | VISHAY INTERTECHNOLOGY INC | Technology | $4.26B | 0.06% |
119LION | LIONSGATE STUDIOS CORP | Communication Services | $4.20B | 0.05% |
120IPAR | INTERPARFUMS INC | Consumer Defensive | $4.19B | 0.05% |
121NVST | ENVISTA HOLDINGS CORP | Healthcare | $3.95B | 0.05% |
122MSGE | MADISON SQUARE GARDEN ENTERTAINMENT CORP | Consumer Cyclical | $3.74B | 0.05% |
123OGN | ORGANON & CO | Healthcare | $3.65B | 0.05% |
124ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | $3.48B | 0.04% |
125HGV | HILTON GRAND VACATIONS INC | Consumer Cyclical | $3.33B | 0.04% |
126WRBY | WARBY PARKER INC | Healthcare | $3.32B | 0.04% |
127PK | PARK HOTELS & RESORTS INC | Real Estate | $3.28B | 0.04% |
128TMDX | TRANSMEDICS GROUP INC | Healthcare | $3.20B | 0.04% |
129ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | $3.14B | 0.04% |
130SHAK | SHAKE SHACK INC | Consumer Cyclical | $3.11B | 0.04% |
131BHC | BAUSCH HEALTH COMPANIES INC | Healthcare | $3.09B | 0.04% |
132OSW | ONESPAWORLD HOLDINGS LTD | Consumer Cyclical | $3.07B | 0.04% |
133XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | $3.04B | 0.04% |
134ADMA | ADMA BIOLOGICS INC | Healthcare | $2.94B | 0.04% |
135VCEL | VERICEL CORP | Healthcare | $2.93B | 0.04% |
136ATRC | ATRICURE INC | Healthcare | $2.85B | 0.04% |
137RSI | RUSH STREET INTERACTIVE INC | Consumer Cyclical | $2.72B | 0.04% |
138IMAX | IMAX CORP | Communication Services | $2.64B | 0.03% |
139NEOG | NEOGEN CORP | Healthcare | $2.44B | 0.03% |
140UFPT | UFP TECHNOLOGIES INC | Healthcare | $2.37B | 0.03% |
141PENN | PENN ENTERTAINMENT INC | Consumer Cyclical | $2.35B | 0.03% |
142SHO | SUNSTONE HOTEL INVESTORS INC | Real Estate | $2.24B | 0.03% |
143AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | $2.17B | 0.03% |
144PBH | PRESTIGE CONSUMER HEALTHCARE INC | Healthcare | $2.15B | 0.03% |
145SUPN1 | SUPERNUS PHARMACEUTICALS INC | Healthcare | $2.11B | 0.03% |
146XHR | XENIA HOTELS & RESORTS INC | Real Estate | $2.01B | 0.03% |
147HRMY | HARMONY BIOSCIENCES HOLDINGS INC | Healthcare | $1.98B | 0.03% |
148MCRI | MONARCH CASINO & RESORT INC | Consumer Cyclical | $1.95B | 0.03% |
149WHR | WHIRLPOOL CORP | Consumer Cyclical | $1.90B | 0.02% |
150XRAY | DENTSPLY SIRONA INC | Healthcare | $1.83B | 0.02% |
151ZYME | ZYMEWORKS INC | Healthcare | $1.83B | 0.02% |
152PRKS | UNITED PARKS & RESORTS INC | Consumer Cyclical | $1.82B | 0.02% |
153LMAT | LEMAITRE VASCULAR INC | Healthcare | $1.78B | 0.02% |
154ETON | ETON PHARMACEUTICALS INC | Healthcare | $1.77B | 0.02% |
155INSP | INSPIRE MEDICAL SYSTEMS INC | Healthcare | $1.75B | 0.02% |
156SRPT | SAREPTA THERAPEUTICS INC | Healthcare | $1.72B | 0.02% |
157NRIX | NURIX THERAPEUTICS INC | Healthcare | $1.70B | 0.02% |
158PLAB | PHOTRONICS INC | Technology | $1.64B | 0.02% |
159ANIP | ANI PHARMACEUTICALS INC | Healthcare | $1.62B | 0.02% |
160WEN | WENDY'S CO | Consumer Cyclical | $1.56B | 0.02% |
161SCL | STEPAN CO | Basic Materials | $1.51B | 0.02% |
162CNMD | CONMED CORP | Healthcare | $1.50B | 0.02% |
163SG | SWEETGREEN INC | Consumer Cyclical | $1.48B | 0.02% |
164EYE | NATIONAL VISION HOLDINGS INC | Consumer Cyclical | $1.47B | 0.02% |
165PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.46B | 0.02% |
166CBRL | CRACKER BARREL OLD COUNTRY STORE INC | Consumer Cyclical | $1.45B | 0.02% |
167PAHC | PHIBRO ANIMAL HEALTH CORP | Healthcare | $1.44B | 0.02% |
168ANAB | ANAPTYSBIO INC | Healthcare | $1.43B | 0.02% |
169CDRE | CADRE HOLDINGS INC | Industrials | $1.42B | 0.02% |
170INVA | INNOVIVA INC | Healthcare | $1.35B | 0.02% |
171STAA | STAAR SURGICAL CO | Healthcare | $1.34B | 0.02% |
172LZB | LA-Z-BOY INC | Consumer Cyclical | $1.30B | 0.02% |
173OMER | OMEROS CORP | Healthcare | $1.30B | 0.02% |
174AMPH | AMPHASTAR PHARMACEUTICALS INC | Healthcare | $1.23B | 0.02% |
175BJRI | BJS RESTAURANTS INC | Consumer Cyclical | $1.20B | 0.02% |
176VOR | VOR BIOPHARMA INC | Healthcare | $1.19B | 0.02% |
177TH | TARGET HOSPITALITY CORP | Industrials | $1.17B | 0.02% |
178IART | INTEGRA LIFESCIENCES HOLDINGS CORP | Healthcare | $1.12B | 0.01% |
179ACEL | ACCEL ENTERTAINMENT INC | Consumer Cyclical | $1.11B | 0.01% |
180ATEC | ALPHATEC HOLDINGS INC | Healthcare | $1.10B | 0.01% |
181IRMD | IRADIMED CORP | Healthcare | $1.09B | 0.01% |
182HROW | HARROW INC | Healthcare | $1.06B | 0.01% |
183APOG | APOGEE ENTERPRISES INC | Industrials | $991M | 0.01% |
184AORT | ARTIVION INC | Healthcare | $947M | 0.01% |
185BVS | BIOVENTUS INC | Healthcare | $915M | 0.01% |
186CODI | COMPASS DIVERSIFIED HOLDINGS | Industrials | $888M | 0.01% |
187BH | BIGLARI HOLDINGS INC | Consumer Cyclical | $880M | 0.01% |
188HELE | HELEN OF TROY LTD | Consumer Defensive | $870M | 0.01% |
189BLMN | BLOOMIN' BRANDS INC | Consumer Cyclical | $868M | 0.01% |
190RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | $860M | 0.01% |
191MCS | MARCUS CORP | Communication Services | $846M | 0.01% |
192MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | $844M | 0.01% |
193FUBO | FUBOTV INC | Communication Services | $838M | 0.01% |
194FWRG | FIRST WATCH RESTAURANT GROUP INC | Consumer Cyclical | $799M | 0.01% |
195COLL | COLLEGIUM PHARMACEUTICAL INC | Healthcare | $775M | 0.01% |
196DCTH | DELCATH SYSTEMS INC | Healthcare | $744M | 0.01% |
197QDEL | QUIDELORTHO CORP | Healthcare | $729M | 0.01% |
198MOV | MOVADO GROUP INC | Consumer Cyclical | $713M | 0.01% |
199RSVR | RESERVOIR MEDIA INC | Communication Services | $675M | 0.01% |
200ZVRA | ZEVRA THERAPEUTICS INC | Healthcare | $664M | 0.01% |
201PZZA | PAPA JOHNS INTERNATIONAL INC | Consumer Cyclical | $631M | 0.01% |
202TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Healthcare | $601M | 0.01% |
203FOSL | FOSSIL GROUP INC | Consumer Cyclical | $517M | 0.01% |
204PTLO | PORTILLO'S INC | Consumer Cyclical | $509M | 0.01% |
205BRCB | BLACK ROCK COFFEE BAR INC | Consumer Cyclical | $483M | 0.01% |
206KE | KIMBALL ELECTRONICS INC | Industrials | $482M | 0.01% |
207LOCO | EL POLLO LOCO HOLDINGS INC | Consumer Cyclical | $447M | 0.01% |
208DIN | DINE BRANDS GLOBAL INC | Consumer Cyclical | $447M | 0.01% |
209ETD | ETHAN ALLEN INTERIORS INC | Consumer Cyclical | $446M | 0.01% |
210XMAX | XMAX INC | Consumer Cyclical | $423M | 0.01% |
211PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | $418M | 0.01% |
212HBB | HAMILTON BEACH BRANDS HOLDING CO | Consumer Cyclical | $410M | 0.01% |
213CVEO | CIVEO CORP | Industrials | $376M | 0.00% |
214EMBC | EMBECTA CORP | Healthcare | $364M | 0.00% |
215KRUS | KURA SUSHI USA INC | Consumer Cyclical | $322M | 0.00% |
216FLXS | FLEXSTEEL INDUSTRIES INC | Consumer Cyclical | $313M | 0.00% |
217AGEN | AGENUS INC | Healthcare | $311M | 0.00% |
218INFU | INFUSYSTEM HOLDINGS INC | Healthcare | $296M | 0.00% |
219OFIX | ORTHOFIX MEDICAL INC | Healthcare | $283M | 0.00% |
220PLAY | DAVE & BUSTER'S ENTERTAINMENT INC | Communication Services | $273M | 0.00% |
221JACK | JACK IN THE BOX INC | Consumer Cyclical | $270M | 0.00% |
222NC | NACCO INDUSTRIES INC | Energy | $266M | 0.00% |
223QTTB | Q32 BIO INC | Healthcare | $264M | 0.00% |
224USNA | USANA HEALTH SCIENCES INC | Consumer Defensive | $235M | 0.00% |
225UTMD | UTAH MEDICAL PRODUCTS INC | Healthcare | $234M | 0.00% |
226PDEX | PRO DEX INC | Healthcare | $216M | 0.00% |
227RICK | RCI HOSPITALITY HOLDINGS INC | Consumer Cyclical | $207M | 0.00% |
228ELMD | ELECTROMED INC | Healthcare | $204M | 0.00% |
229BSET | BASSETT FURNITURE INDUSTRIES INC | Consumer Cyclical | $187M | 0.00% |
230ANIK | ANIKA THERAPEUTICS INC | Healthcare | $185M | 0.00% |
231NATR | NATURES SUNSHINE PRODUCTS INC | Consumer Defensive | $178M | 0.00% |
232RRGB | RED ROBIN GOURMET BURGERS INC | Consumer Cyclical | $167M | 0.00% |
233COOK | TRAEGER INC | Consumer Cyclical | $162M | 0.00% |
234KVHI | KVH INDUSTRIES INC | Communication Services | $134M | 0.00% |
235BDL | FLANIGANS ENTERPRISES INC | Consumer Cyclical | $107M | 0.00% |
236SKIN | SKINHEALTH SYSTEMS INC | Consumer Defensive | $104M | 0.00% |
237KEQU | KEWAUNEE SCIENTIFIC CORP | Consumer Cyclical | $104M | 0.00% |
238ICCC | IMMUCELL CORP | Healthcare | $93M | 0.00% |
239RLYB | RALLYBIO CORP | Healthcare | $84M | 0.00% |
240NDLS | NOODLES & CO | Consumer Cyclical | $82M | 0.00% |
241CPHC | CANTERBURY PARK HOLDING CORP | Consumer Cyclical | $81M | 0.00% |
242FTLF | FITLIFE BRANDS INC | Consumer Defensive | $78M | 0.00% |
243APT | ALPHA PRO TECH LTD | Industrials | $64M | 0.00% |
244LFVN | LIFEVANTAGE CORP | Consumer Defensive | $64M | 0.00% |
Full long-leg book as of November 2026 · cap-weighted · total market cap $7.74T. Hypothetical model holdings — not a registered fund’s portfolio.
Size × value map of the long-leg book
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20261113T032607 rows=2198308 asof=202611 issuers=20261113T063725 rates=20261113T063725
Measured on the 2026-11 formation date across 244 holdings (cap-weighted). A different formation date can produce different verdicts.
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 335 monthly observations · about 3.4 in the 99% tail · paired percentile bootstrap over months
The estimators differ materially in value but agree on the verdict. Historical and Gaussian fund VaR differ by 23%; both still land on the same side of the 2x limit.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | -2.2% | -10.2% |
| 3 yearsp.a. | 21.1% | -2.6% |
| 5 yearsp.a. | 10.2% | -3.1% |
| 10 yearsp.a. | 14.1% | -7.6% |
| Since inceptionp.a. | 6.9% | -3.6% |
| Year | Long leg | Long-short |
|---|---|---|
| 202611 mo | -2.2% | -10.4% |
| 2025 | 29.9% | 13.2% |
| 2024 | 31.7% | -8.6% |
| 2023 | 21.4% | -28.1% |
| 2022 | -23.7% | 18.0% |
| 2021 | 32.9% | -1.0% |
| 2020 | 22.5% | -32.2% |
| 2019 | 16.5% | -6.5% |
| 2018 | -0.2% | -7.8% |
| 2017 | 24.5% | -2.4% |
| 2016 | 8.8% | 4.4% |
| 2015 | 1.7% | -13.9% |
| 2014 | 21.0% | 17.6% |
| 2013 | 43.6% | -1.0% |
| 2012 | 10.1% | -12.2% |
| 2011 | 1.7% | 19.4% |
| 2010 | 3.7% | -13.6% |
| 2009 | 17.0% | -12.1% |
| 2008 | -20.4% | 60.1% |
| 2007 | 6.9% | -0.8% |
| 2006 | 12.4% | -2.5% |
| 2005 | 6.6% | 1.8% |
| 2004 | -3.3% | -10.2% |
| 2003 | 22.8% | -14.1% |
| 2002 | -17.2% | 9.6% |
| 2001 | 3.9% | 52.5% |
| 2000 | -36.0% | -26.5% |
| 1999 | 0.0% | -34.3% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through November 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
The Foundry Enterprise Multiple Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a Enterprise Multiple signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,140-name universe at November 2026. Rows: Large ≥ $5.3B, Small < $832M. Columns: Value ≥ 0.62, Growth < 0.33 B/M. The dot marks the capital-weighted centroid of the book — 99% toward Large, 82% toward Growth. +1% unclassified (24 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → November 2026; the right-hand end is the same value as the box’s dot. 244 names now. Hypothetical holdings — descriptive, not P&L.